Verve Therapeutics, Inc. (VERV)
Jul 25, 2025 - VERV was delisted (reason: acquired by LLY)
11.13
0.00 (0.00%)
Inactive · Last trade price on Jul 24, 2025

Accolade Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Net Income
-181.01-198.71-200.07-157.39-120.31-45.7
Upgrade
Depreciation & Amortization
6.846.755.462.81.541.33
Upgrade
Loss (Gain) From Sale of Investments
-10.33-12.41-14.38-1.031.510.38
Upgrade
Stock-Based Compensation
44.0943.2635.1222.487.070.85
Upgrade
Other Operating Activities
5.635.686.632.4235.235.24
Upgrade
Change in Accounts Receivable
4.332.64-5.89-1.01--
Upgrade
Change in Accounts Payable
2.21-1.833.91-5.226.83-1.9
Upgrade
Change in Unearned Revenue
-4.635.3128.5420.01--
Upgrade
Change in Other Net Operating Assets
-9.57-8.38-8.86-5.41-9.744.54
Upgrade
Operating Cash Flow
-142.46-157.69-149.55-122.33-77.88-35.27
Upgrade
Capital Expenditures
-4.53-3.74-9.28-13.23-4.36-3.42
Upgrade
Investment in Securities
72.8778.6136.97-142.72-234.74-47.7
Upgrade
Investing Cash Flow
68.3474.8827.69-155.96-239.1-51.13
Upgrade
Issuance of Common Stock
26.4849.26213.04329.74286.960.01
Upgrade
Other Financing Activities
-0.02-0.07-0.46-0.78-3.63-
Upgrade
Financing Cash Flow
26.4749.2212.58328.96377.0992.63
Upgrade
Net Cash Flow
-47.65-33.6290.7250.6760.116.24
Upgrade
Free Cash Flow
-146.98-161.43-158.83-135.56-82.24-38.69
Upgrade
Free Cash Flow Margin
-246.56%-499.28%-1350.84%-6984.23%--
Upgrade
Free Cash Flow Per Share
-1.71-1.91-2.48-2.51-3.06-17.19
Upgrade
Levered Free Cash Flow
-64.11-95.46-110.19-90.05-42.25-24.46
Upgrade
Unlevered Free Cash Flow
-64.11-95.46-110.19-90.05-42.25-24.46
Upgrade
Change in Net Working Capital
-19.78-1.182.03-1.46-7.92-2.18
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q